Pure Solutions, Inc. Recalls Sleep Supplements Due to Undeclared Milk Allergen
Pure Solutions, Inc. is recalling 442 bottles of sleep supplements distributed across 36 states because the labels fail to declare a milk allergen.
What Happened
Pure Solutions, Inc. of Tampa, Florida, has initiated a voluntary recall of two liquid dietary supplement products. The recall was triggered because the product labels declare bovine colostrum but fail to explicitly declare the presence of a milk allergen. This classification was designated as Class II by the FDA.
Which Products Are Affected
The recall involves 442 individual 1 fl oz (30 ml) bottles. The specific details are as follows:
- Product Names: Pure Factors Professional Nighttime Sleep Formula and Pure Formulas Sleep Reset
- Packaging: Glass bottle with dropper cap
- Lot Number: 0528D911
- Expiration Date: May 2028
- Recall Number: H-0537-2026
The affected units were distributed to the following states: AR, FL, CO, CA, CT, HI, IN, IL, ID, IA, KS, KY, LA, OH, OK, OR, MA, MI, MN, MO, GA, NC, NE, ND, NY, PA, SC, TN, NJ, UT, TX, VA, WA, WV, WI, and WY.
What You Should Do
Consumers who have an allergy or severe sensitivity to milk should stop using these products immediately. Pure Solutions, Inc. has notified affected parties through various methods, including email, fax, letter, and telephone. Consumers with questions regarding returns or refunds should contact the firm directly at their Tampa, FL location.
Why This Matters
For individuals with a milk allergy, consuming these products poses a risk of serious or life-threatening allergic reactions. Accurate allergen labeling is essential for consumer safety and regulatory compliance.
Source
Information provided by the FDA regarding event ID 98413.
Source: FDA Official Notice
Related Articles
Centinel Spine Recalls Prodisc C SK Cervical Disc Replacement Devices Due to Mislabeled Sizing
FDA · March 4, 2026
Medline Industries Recalls 154,427 Convenience Kits Over Sterility Concerns
FDA · March 4, 2026
Medline Industries Recalls Chest/Breast Convenience Kits Due to Sterility Concerns
FDA · March 4, 2026